Combination Chemotherapy in Treating Children With Stage III or Stage IV Non-Hodgkin's Lymphoma or Acute Lymphoblastic Leukemia

PHASE1CompletedINTERVENTIONAL
Enrollment

20

Participants

Timeline

Start Date

March 31, 1998

Primary Completion Date

October 31, 2004

Study Completion Date

September 30, 2006

Conditions
LeukemiaLymphoma
Interventions
BIOLOGICAL

filgrastim

DRUG

cyclophosphamide

DRUG

cytarabine

DRUG

dexamethasone

DRUG

doxorubicin hydrochloride

DRUG

methotrexate

DRUG

vincristine sulfate

Trial Locations (14)

13210

State University of New York - Upstate Medical University, Syracuse

14642

University of Rochester Cancer Center, Rochester

53226

Midwest Children's Cancer Center, Milwaukee

60614

Children's Memorial Hospital, Chicago, Chicago

72205

University of Arkansas for Medical Sciences, Little Rock

76104

Cook Children's Medical Center - Fort Worth, Fort Worth

94304

Lucile Packard Children's Hospital at Stanford, Palo Alto

07601

Hackensack University Medical Center, Hackensack

14263-0001

Roswell Park Cancer Institute, Buffalo

73126-0307

Oklahoma Memorial Hospital, Oklahoma City

29425-0721

Medical University of South Carolina, Charleston

75235-9154

Simmons Cancer Center - Dallas, Dallas

T2T 5C7

Alberta Children's Hospital, Calgary

M5G 1X8

Hospital for Sick Children, Toronto

All Listed Sponsors
collaborator

National Cancer Institute (NCI)

NIH

lead

Children's Oncology Group

NETWORK

NCT00003217 - Combination Chemotherapy in Treating Children With Stage III or Stage IV Non-Hodgkin's Lymphoma or Acute Lymphoblastic Leukemia | Biotech Hunter | Biotech Hunter